Sysmex (OTCMKTS:SSMXY) Sees Unusually-High Trading Volume – Here’s What Happened

Sysmex Corporation ADR (OTCMKTS:SSMXY – Get Free Report) shares saw an uptick in trading volume on Tuesday. Approximately 500,977 shares traded hands during trading, an increase of 160% from the previous session’s volume of 192,975 shares. The stock last traded at $11.7863 and had previously closed at $11.72.

Wall Street Analyst Weigh In

Separately, Zacks Research upgraded shares of Sysmex from a “strong sell” rating to a “hold” rating in a research note on Tuesday, August 18th. Two equities research analysts have rated the stock with a Hold rating. According to MarketBeat, the stock presently has an average rating of “Hold”.

Check Out Our Latest Research Report on Sysmex

Sysmex Trading Up 0.2%

The company has a debt-to-equity ratio of 0.23, a quick ratio of 2.53 and a current ratio of 3.40. The business’s 50-day moving average is $11.83 and its two-hundred day moving average is $9.98. The stock has a market capitalization of $7.14 billion, a PE ratio of 27.95 and a beta of 1.18.

Sysmex (OTCMKTS:SSMXY – Get Free Report) last posted its quarterly earnings results on Friday, August 7th. The company reported $0.09 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.07 by $0.02. Sysmex had a net margin of 7.62% and a return on equity of 8.01%. The firm had revenue of $825.85 million during the quarter, compared to analysts’ expectations of $741.67 million. Sysmex has set its FY 2026 guidance at 0.382-0.382 EPS. As a group, equities research analysts anticipate that Sysmex Corporation ADR will post 0.41 earnings per share for the current year.

About Sysmex

(Get Free Report)

Sysmex Corporation is a Japan-based healthcare technology company that develops, manufactures and distributes in vitro diagnostic products and laboratory solutions. The company is best known for its automated hematology analyzers, which are used to examine blood cells, along with related reagents, software and support services.

Its product portfolio also includes systems for hemostasis, urinalysis, clinical chemistry and immunochemistry, as well as laboratory automation and information-management solutions.

See Also

Receive News & Ratings for Sysmex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sysmex and related companies with MarketBeat.com's FREE daily email newsletter.